【持续性肾脏替代治疗CRRT英文ppt课件】CBP Nephrology – Diseases of the kidneys!(102p).ppt

CBP: Nephrology – Diseases of the kidneys!;CBP: Nephrology ;CBP: Nephrology ;CBP: Nephrology ;Question 1;Diuretics in AKI;Diuretics in AKI;Electrolytes Fluid*;Conversion of oliguric to non-oliguric RF;Confounders;Cause vs Correlate;Diuretics in AKI;Question 2;Definitions of AKI;The dilemma;AKI vs Acute/Chronic RF;;RIFLE vs AKIN;Bottom Line;Question 3;Incidence of AKI in the ICU;AKI and mortality;AKI and other outcomes;Question 4;Traditional methods for detecting AKI;Serum creatinine;Serum creatinine;Urea;Urine output;Summary of novel markers;CBP: Nephrology ;Question 6;Historical aspects;“Indisputable” indications;Other Indications;Timing of initiation of RRT;Teschan et al. Prophylactic hemodialysis in the treatment of acute renal failure. Ann Int Med 1960.;Early studies;Bouman et al (CCM 2002);Jiang, et al (2005);Gettings et al (ICM 1999);Piccini et al. (ICM 2006);Elahi et al. (2004);Demirkilic et al. (2004);Summary;Summary;Shiao et al. (2009);RIFLE/AKIN;Results;Conclusions/Limitations;Question 7;RRT modalities;Diffusion;Convection;SCUF;CVVH;CVVHD;CVVHDF;IHD;Renal Replacement Therapy;Question 8;Dialysis modality;So: is CRRT better?;Preference of CRRT – Putative advantages;Disadvantages;Evidence;Cochrane Review 2008;Objectives;Methods;Methods;Results – Mortality;Results – Recovery of RF;Results – Cardiovascular stability;Results – Complications of RRT;Conclusions;Limitations;What kind of anticoagulation should be used with CRRT?;Introduction;Heparin;Citrate;Citrate versus heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study;Mehran et al.;Mehran et al.;Regional citrate versus systemic heparinization for continuous renal replacement in critically ill patients.;Demetrios et al.;Demetrios et al.;Conclusions: Citrate is better;What are we doing at VGH?;What is the ideal dialysis dose?;Dialysis dosing;VA/NIH;VA/NIH;RENAL;RENAL;Conclusion: Equal